Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock

Heart

Volumn 103, Issue 15, 2017, Pages 1177-1184

  Ledwoch, Jakob ^a,b   Fuernau, Georg ^a,b   Desch, Steffen ^a,b   Eitel, Ingo ^a,b   Jung, Christian ^c   De Waha, Suzanne ^a,b   Poess, Janine ^a,b   Schneider, Steffen ^d   Schuler, Gerhard ^e   Werdan, Karl ^f   Zeymer, Uwe ^d,g   Thiele, Holger ^a,b  

^a University Heart Center Lübeck   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d Institut fur Herzinfarktforschung   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^g KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Acute myocardial infarction; Percutaneous coronary intervention

Indexed keywords

HEMOGLOBIN;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; ATRIAL FIBRILLATION; BARE METAL STENT; CARDIOGENIC SHOCK; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; DYSLIPIDEMIA; EARLY INTERVENTION; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAAORTIC BALLOON PUMP; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIAL; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SHOCK, CARDIOGENIC; STENT; TIME FACTOR;

AGED; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; STENTS; TIME FACTORS;

EID: 85024492545     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-310403     Document Type: Article

References (25)

1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999;341:625-34
2. Räber L, Kelbæk H, Taniwaki M, et al; COMFORTABLE AMI Trial Investigators. Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial. Circ Cardiovasc Interv 2014;7:355-64
3. Sabaté M, Brugaletta S, Cequier A, et al. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Lancet 2016;387:357-66
4. Windecker S, Kolh P, Alfonso F, et al. Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619
5. Amsterdam EA, Wenger NK, Brindis RG, et al; ACC/AHA Task Force MembersSociety for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. 2014 AHA/ACC guideline for the management of patients with non-STelevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;130:2354-94
6. O'Gara PT, Kushner FG, Ascheim DD, et al; CF/AHA Task Force. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:529-55
7. Anderson ML, Peterson ED, Peng SA, et al. Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: a report from NCDR. Circ Cardiovasc Qual Outcomes 2013;6:708-15
8. Wayangankar SA, Bangalore S, McCoy LA, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary Interventions for cardiogenic Shock in the setting of acute myocardial Infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv 2016;9:341-51
9. Jaguszewski M, Ghadri JR, Seifert B, et al. Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis. J Cardiovasc Med 2015;16:220-9
10. Champion S, Gaüzère BA, Lefor Y. Drug-eluting stents should not be used in ST-elevated myocardial infarction with cardiogenic shock. Arch Intern Med 2012;172:1613-4
11. Thiele H, Schuler G, Neumann FJ, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic Balloon Pump in cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 2012;163:938-45
12. Thiele H, Zeymer U, Neumann FJ, et al; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012;367:1287-96
13. Thiele H, Zeymer U, Neumann FJ, et al; Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013;382:1638-45
14. Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007;297:1992-2000
15. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30
16. Win HK, Caldera AE, Maresh K, et al; EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007;297:2001-9
17. Nakazawa G, Finn AV, Vorpahl M, et al. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus-and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57:390-8
18. Sabaté M, Räber L, Heg D, et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. JACC Cardiovasc Interv 2014;7:55-63
19. Räber L, Kelbæk H, Ostojic M, et al; COMFORTABLE AMI Trial Investigators. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA 2012;308:777-87
20. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, et al; DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005;112:2175-83
21. Bønaa KH, Mannsverk J, Wiseth R, et al; NORSTENT Investigators. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med 2016;375:1242-52
22. Urban P, Meredith IT, Abizaid A, et al; LEADERS FREE Investigators. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 2015;373:2038-47
23. Valgimigli M, Patialiakas A, Thury A, et al. Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates study. Am Heart J 2013;166:831-8
24. Valgimigli M, Patialiakas A, Thury A, et al; ZEUS Investigators. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates. J Am Coll Cardiol 2015;65:805-15
25. Silber S, Albertsson P, Francisco F, et al. Guidelines for percutaneous coronary Interventions: the task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47